Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sean Ekins

Showing results (191-200 of 374) with videos related to

Pageof 38
Sort By:
Environmental Health Perspectives|June 19, 2010
Evaluation of computational docking to identify pregnane X receptor agonists in the ToxCast databaseSandhya Kortagere, Matthew D Krasowski, Erica J Reschly, et al.
Pharmaceutical Research|May 6, 2009
Elucidating the 'Jekyll and Hyde' nature of PXR: the case for discovering antagonists or allosteric antagonistsArunima Biswas, Sridhar Mani, Matthew R Redinbo, et al.
Drug Discovery Today|September 20, 2011
Mobile apps for chemistry in the world of drug discoveryAntony J Williams, Sean Ekins, Alex M Clark, et al.
Nature Materials|April 20, 2019
Opportunities and challenges using artificial intelligence in ADME/ToxBarun Bhhatarai, W Patrick Walters, Cornelis E C A Hop, et al.
Metabolites|April 28, 2023
Targeted Metabolomics of Organophosphate Pesticides and Chemical Warfare Nerve Agent Simulants Using High- and Low-Dose Exposure in Human Liver MicrosomesGarima Agarwal, Hunter Tichenor, Sarah Roo, et al.
Molecular Pharmacology|February 7, 2025
Repurposing lapatinib as a triple antagonist of chemokine receptors 3, 4, and 5Thomas R Lane, Ana C Puhl, Patricia A Vignaux, et al.
The Journal of Pharmacology and Experimental Therapeutics|April 19, 2002
Three-dimensional quantitative structure-activity relationship for inhibition of human ether-a-go-go-related gene potassium channelSean Ekins, William J Crumb, R Dustan Sarazan, et al.
Pharmaceutical Research|October 18, 2013
Combining computational methods for hit to lead optimization in Mycobacterium tuberculosis drug discoverySean Ekins, Joel S Freundlich, Judith V Hobrath, et al.
Pharmaceutical Research|July 24, 2019
Repurposing Approved Drugs as Inhibitors of K<sub>v</sub>7.1 and Na<sub>v</sub>1.8 to Treat Pitt Hopkins SyndromeSean Ekins, Jacob Gerlach, Kimberley M Zorn, et al.
F1000Research|August 8, 2017
Machine learning models identify molecules active against the Ebola virus <i>in vitro</i>Sean Ekins, Joel S Freundlich, Alex M Clark, et al.
Pageof 38

Showing results (191-200 of 374) with videos related to

Sort By:
Pageof 38
Environmental Health Perspectives|June 19, 2010
Evaluation of computational docking to identify pregnane X receptor agonists in the ToxCast databaseSandhya Kortagere, Matthew D Krasowski, Erica J Reschly, et al.
Pharmaceutical Research|May 6, 2009
Elucidating the 'Jekyll and Hyde' nature of PXR: the case for discovering antagonists or allosteric antagonistsArunima Biswas, Sridhar Mani, Matthew R Redinbo, et al.
Drug Discovery Today|September 20, 2011
Mobile apps for chemistry in the world of drug discoveryAntony J Williams, Sean Ekins, Alex M Clark, et al.
Nature Materials|April 20, 2019
Opportunities and challenges using artificial intelligence in ADME/ToxBarun Bhhatarai, W Patrick Walters, Cornelis E C A Hop, et al.
Metabolites|April 28, 2023
Targeted Metabolomics of Organophosphate Pesticides and Chemical Warfare Nerve Agent Simulants Using High- and Low-Dose Exposure in Human Liver MicrosomesGarima Agarwal, Hunter Tichenor, Sarah Roo, et al.
Molecular Pharmacology|February 7, 2025
Repurposing lapatinib as a triple antagonist of chemokine receptors 3, 4, and 5Thomas R Lane, Ana C Puhl, Patricia A Vignaux, et al.
The Journal of Pharmacology and Experimental Therapeutics|April 19, 2002
Three-dimensional quantitative structure-activity relationship for inhibition of human ether-a-go-go-related gene potassium channelSean Ekins, William J Crumb, R Dustan Sarazan, et al.
Pharmaceutical Research|October 18, 2013
Combining computational methods for hit to lead optimization in Mycobacterium tuberculosis drug discoverySean Ekins, Joel S Freundlich, Judith V Hobrath, et al.
Pharmaceutical Research|July 24, 2019
Repurposing Approved Drugs as Inhibitors of K<sub>v</sub>7.1 and Na<sub>v</sub>1.8 to Treat Pitt Hopkins SyndromeSean Ekins, Jacob Gerlach, Kimberley M Zorn, et al.
F1000Research|August 8, 2017
Machine learning models identify molecules active against the Ebola virus <i>in vitro</i>Sean Ekins, Joel S Freundlich, Alex M Clark, et al.
Pageof 38